Gene · 407014
Papers3,611
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
341 to 360 of 3,611
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| MicroRNA-122 in human cancers: from mechanistic to clinical perspectives. | Cancer Cell Int | 2023 | 36803831 | PubTator, text mining | PubMed |
| Emerging role of mesenchymal stem/stromal cells (MSCs) and MSCs-derived exosomes in bone- and joint-associated musculoskeletal disorders: a new frontier. | Eur J Med Res | 2023 | 36803566 | PubTator, text mining | PubMed |
| Tanshinone IIA and hepatocellular carcinoma: A potential therapeutic drug. | Front Oncol | 2023 | 36798821 | PubTator, text mining | PubMed |
| Recent advances of small extracellular vesicle biomarkers in breast cancer diagnosis and prognosis. | Mol Cancer | 2023 | 36797736 | PubTator, text mining | PubMed |
| Omics approaches to understanding the efficacy and safety of disease-modifying treatments in multiple sclerosis. | Front Genet | 2023 | 36793897 | PubTator, text mining | PubMed |
| Molecular pathways that drive diabetic kidney disease. | J Clin Invest | 2023 | 36787250 | PubTator, text mining | PubMed |
| High aspect ratio nanomaterial-induced macrophage polarization is mediated by changes in miRNA levels. | Front Immunol | 2023 | 36776851 | PubTator, text mining | PubMed |
| DNA replication: Mechanisms and therapeutic interventions for diseases. | MedComm (2020) | 2023 | 36776764 | PubTator, text mining | PubMed |
| DNA methylation changes and increased mRNA expression of coagulation proteins, factor V and thrombomodulin in Fuchs endothelial corneal dystrophy. | Cell Mol Life Sci | 2023 | 36773096 | PubTator, text mining | PubMed |
| Finding the Needle in the Haystack: Serological and Urinary Biomarkers in Behçet's Disease: A Systematic Review. | Int J Mol Sci | 2023 | 36769366 | PubTator, text mining | PubMed |
| The Relationship between Serum miRNAs and Early Mortality in Multiple Myeloma Patients Treated with Bortezomib-Based Regimens. | Int J Mol Sci | 2023 | 36769265 | PubTator, text mining | PubMed |
| Insights into the Molecular Mechanisms Regulating Cell Behavior in Response to Magnetic Materials and Magnetic Stimulation in Stem Cell (Neurogenic) Differentiation. | Int J Mol Sci | 2023 | 36768351 | PubTator, text mining | PubMed |
| Non-Coding RNAs in Pulmonary Diseases: Comparison of Different Airway-Derived Biosamples. | Int J Mol Sci | 2023 | 36768329 | PubTator, text mining | PubMed |
| Epigenetic Alterations in Canine Malignant Lymphoma: Future and Clinical Outcomes. | Animals (Basel) | 2023 | 36766357 | PubTator, text mining | PubMed |
| MicroRNAs in the Pathogenesis, Prognostication and Prediction of Treatment Resistance in Soft Tissue Sarcomas. | Cancers (Basel) | 2023 | 36765536 | PubTator, text mining | PubMed |
| Targeting and regulation of autophagy in hepatocellular carcinoma: revisiting the molecular interactions and mechanisms for new therapy approaches. | Cell Commun Signal | 2023 | 36759819 | PubTator, text mining | PubMed |
| Human pancreatic islet microRNAs implicated in diabetes and related traits by large-scale genetic analysis. | Proc Natl Acad Sci U S A | 2023 | 36757889 | PubTator, text mining | PubMed |
| MicroRNA expression profiling of RAS-mutant thyroid tumors with follicular architecture: microRNA signatures to discriminate benign from malignant lesions. | J Endocrinol Invest | 2023 | 36749451 | PubTator, text mining | PubMed |
| The immunomodulatory effect of intradermal allogeneic PBMC therapy in patients with recurrent spontaneous abortion. | J Reprod Immunol | 2023 | 36746007 | PubTator, text mining | PubMed |
| The SIK1/CRTC2/CREB1 and TWIST1/PI3K/Akt/GSK3β signaling pathways mediated by microRNA-25-3p are altered in the schizophrenic rat brain. | Front Cell Neurosci | 2023 | 36744005 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/407014/papers?page=18